Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000097

Options or other derivatives

  • See Remarks acquired 152,570 shares (grant or award)
  • See Remarks returned 331,250 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Symons Julian A. See Remarks 2024-02-27 Returned to the company · Stock Option (Right to Buy) −200,000 0 D: show line 1 in the form
Symons Julian A. See Remarks 2024-02-27 Returned to the company · Stock Option (Right to Buy) −105,000 0 D: show line 2 in the form
Symons Julian A. See Remarks 2024-02-27 Returned to the company · Stock Option (Right to Buy) −26,250 0 D: show line 3 in the form
Symons Julian A. See Remarks 2024-02-28 Grant or award · Stock Option (Right to Buy) +58,822 58,822 D: show line 4 in the form
Symons Julian A. See Remarks 2024-02-28 Grant or award · Stock Option (Right to Buy) +74,998 74,998 D: show line 5 in the form
Symons Julian A. See Remarks 2024-02-28 Grant or award · Stock Option (Right to Buy) +18,750 18,750 D: show line 6 in the form
Loading xslF345X05/form4.xml…